Literature DB >> 21686871

Morning pseudoneutropenia during risperidone treatment.

Gurinder Singh1, Sreekant Kodela.   

Abstract

Risperidone, an atypical antipsychotic drug, is associated with neutropenia in some individuals. When the absolute neutrophil count falls below 1.8×10(9)/l clinicians may consider switching the drug. We report the case of a young man who developed neutropenia while on risperidone and also showed a pronounced diurnal variation, with normal neutrophil counts later in the day. Hence neutrophil counts should be measured in the afternoon sample before making modifications to the therapeutic agent based only on a early morning sample.

Entities:  

Year:  2009        PMID: 21686871      PMCID: PMC3029895          DOI: 10.1136/bcr.06.2008.0288

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

Review 1.  Benign ethnic neutropenia: what is a normal absolute neutrophil count?

Authors:  T B Haddy; S R Rana; O Castro
Journal:  J Lab Clin Med       Date:  1999-01

2.  PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP.

Authors:  M S GUTTMACHER
Journal:  Arch Gen Psychiatry       Date:  1964-03

3.  Risperidone-induced leucopenia and neutropenia: a case report.

Authors:  Myrthe Sluys; Yener Güzelcan; Gerty Casteelen; Lieuwe de Haan
Journal:  Eur Psychiatry       Date:  2004-04       Impact factor: 5.361

4.  Risperidone-induced morning pseudoneutropenia.

Authors:  David Esposito; Emmanuelle Corruble; Patrick Hardy; Guy Chouinard
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

5.  Circadian rhythm of white blood cells during clozapine treatment.

Authors:  A Ahokas; E Elonen
Journal:  Psychopharmacology (Berl)       Date:  1999-06       Impact factor: 4.530

6.  Circadian variation of granulocyte colony stimulating factor levels in man.

Authors:  B Jilma; N Hergovich; P Stohlawetz; H G Eichler; P Bauer; O F Wagner
Journal:  Br J Haematol       Date:  1999-08       Impact factor: 6.998

  6 in total
  2 in total

1.  Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort.

Authors:  Vissagan Gopalakrishnan; Amanda M Jones; Patricia Julien-Williams; Tania Machado; Robert L Danner; Jeffrey J Swigris; Robert Paine; Jay N Lozier; Joel Moss
Journal:  ERJ Open Res       Date:  2018-03-20

2.  Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion.

Authors:  Allison Karst; Jonathan Lister
Journal:  Ment Health Clin       Date:  2018-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.